1 |
Wallace DC. Mitochondrial diseases in man and mouse. Science 1999;283:1482-8
DOI
ScienceOn
|
2 |
Kroemer G, Dallaporta B, Resche-Rigon M. The mitochondrial death/life regulator in apoptosis and necrosis. Ann Rev Physiol 1998;60:619-42
DOI
ScienceOn
|
3 |
Labajova A, Vojtiskova A, Krivakova P, Kofranek J, Drahota Z, Houstek J. Evaluation of mitochondrial membrane potential using a computerized device with a tetraphenylphosphoniumselective electrode. Anal. Biochem 2006;353:37-42
DOI
ScienceOn
|
4 |
Kailasnath P, Sinusas AJ. Comparison of Tl-201 with Tc-99m-labeled myocardial perfusion agents: technical, physiologic, and clinical issues. J Nucl Cardiol 2001;8:482-98
DOI
ScienceOn
|
5 |
Matsunari I, Tanishima Y, Taki J, et al. Early and delayed technetium-99m-tetrofosmin myocardial SPECT compared in normal volunteers. J Nucl Med 1996;37:1622-26
|
6 |
Chua T, Kiat H, Germano G, et al. Rapid back to back adenosine stress/rest technetium-99m teboroxime myocardial perfusion SPECT using a triple-detector camera. J Nucl Med 1993;34:1485-93
|
7 |
Madar I, Weiss L, Izbicki G. Preferential Accumulation of HTetraphenylphosphonium in NonSmall Cell Lung Carcinoma in Mice: Comparison with 99mTc-MIBI. J Nucl Med 2002;43:234-8
|
8 |
Cheng Z, Subbarayan M, Chen X, Gambhir SS. Synthesis of (4-[ F]fluorophenyl) Triphenylphosphonium as a potential imaging agent for mitochondrial dysfunction. J Label Compd Radiopharm 2005;48:131-7
DOI
ScienceOn
|
9 |
Nuyts J, Dupont P, Van den Maegdenbergh V, Vleugels S, Suetens P, Mortelmans L. A study of the liver-heart artifact in emission tomography. J Nucl Med 1995;36:133-9
|
10 |
Higley B, Smith FW, Smith T, et al. Technetium-99m-1,2-bis [bis(2-ethoxyethyl)phosphino] ethan: biodistribution, dosimetry and safety of a new myocardial perfusion imaging agent. J Nucl Med 1993;34:30-8
|
11 |
Massoud TF, Gambhir SS. Molecular imaging in living subjects: seeing fundamental biological processes in a new light. GENES & DEVELOPMENT 2003;17:545-80
DOI
ScienceOn
|
12 |
Cavalli LR, Liang BC. Mutagenesis, tumorigenicity, and apoptosis: are the mitochondria involved? Mutat Res 1998;398:1926
|
13 |
Min JJ, Biswal S, Deroose C, Gambhir SS. Tetraphenylphosphonium as a Novel Molecular Probe for Imaging Tumors. J Nucl Med 2004;45:4 636-43
|
14 |
Germano G, Chua T, Kiat H, Areeda JS, Berman DS. A quantitative phantom analysis of artifacts due to hepatic activity in technetium-99m myocardial perfusion SPECT studies. J Nucl Med 1994;35:356-9
|
15 |
Burns HD, Marzilli LG, Dannals RF, Dannals TE, Trageser TC, Conti P et al. 4-[ I] Iodophenyltrimethylammonium Ion, an Iodinated Acetylcholinesterase Inhibitor with Potential as a Myocardial Imaging Agent. J Nucl Med 1980;21:875-9
|
16 |
Lambert C, Gaschler W, Noll G, Weber M, Schmalzlin E, Brauchle C, Meerholz K. Cationic -electron systems with high quadratic hyperpolarisability. J Chem Soc Perkin Trans 2 2001;6:964-74
|
17 |
Hatada K, Riou LM, Ruiz M, Yamamichi Y, Duatti A, Lima RL et al. Tc-N-DBODC5, a New Myocardial Perfusion Imaging Agent with Rapid Liver Clearance: Comparison with Tc-Sestamibi and Tc-Tetrofosmin in Rats. J Nucl Med 2004;45:2095-101
|